Chemotherapy and Radiotherapy in the Management of the Malignant Lymphomas

  • A. M. Jelliffe
  • Y. L. Millett
Part of the Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer book series (RECENTCANCER, volume 46)

Summary

This paper is restricted to discussion of malignant lymphomas originating primarily in the lymph nodes. During the last decade there has been a dramatic change in the management of patients with lymphomas, due to improvements in radiotherapy, in chemotherapy, in investigations to determine the extent of the disease, and above all to our acceptance that lymphomas are not always fatal.

It is now accepted that many patients with Hodgkin’s disease are curable by radiotherapy. We believe that many patients with lymphosarcoma and reticulo- sarcoma can also be cured. The efficiency of modern radiotherapy and cancer chemotherapy makes it sometimes difficult to select the best method of treatment for a particular patient.

Keywords

Lymphoma Sarcoma Methotrexate Cyclophosphamide Prednisone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bennett, M. H., Millett, Y. L.: Clin. Radiol. 20, 339 (1969).PubMedCrossRefGoogle Scholar
  2. 2.
    Harrison, C. V.: In: Recent Advances in Pathology, No. 8, p. 232. (Harrison, C. V., Ed.) London: Churchill 1966.Google Scholar
  3. 3.
    Millett, Y. L., Bennett, M. H., Jelliffe, A. M., Farrer-brown, G.: Brit. J. Cancer 23, 683 (1969).PubMedCrossRefGoogle Scholar
  4. 4.
    Rappaport, H.: In:The Lymphoreticular Tumors in Africa, P. 174. (Roulet, F. C., Ed.) Basel: Karger 1963.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • A. M. Jelliffe
  • Y. L. Millett

There are no affiliations available

Personalised recommendations